Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

UBS
Citi
QuintilesIMS
Boehringer Ingelheim
McKinsey
Covington
Queensland Health
Daiichi Sankyo
Fuji
Accenture

Generated: December 10, 2017

DrugPatentWatch Database Preview

US Patents With Foreign Priority to Germany Patent: 10 2004 062 864

« Back to Dashboard


Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Patented / Exclusive Use
Boehringer IngelheimPRADAXAdabigatran etexilate mesylateCAPSULE;ORAL022512-001Oct 19, 2010RXYesNo► Subscribe► Subscribe► SubscribeYY
Boehringer IngelheimPRADAXAdabigatran etexilate mesylateCAPSULE;ORAL022512-002Oct 19, 2010RXYesYes► Subscribe► Subscribe► SubscribeYY
Boehringer IngelheimPRADAXAdabigatran etexilate mesylateCAPSULE;ORAL022512-003Nov 20, 2015RXYesNo► Subscribe► Subscribe► SubscribeYY
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Table 'thinkbio_newdpw.patent_gazette' doesn't exist